Revance Therapeutics, Inc. Real Estate Contracts & Agreements

7 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Third Amendment to Lease dated January 13, 2023, by and between Revance Therapeutics, Inc. and 1222 Demonbreun, LP
Lease Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2023
Second Amendment to Lease, dated July 1, 2021 by and between Revance Therapeutics, Inc and 1222 Demonbreun, LP
Lease Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2021
Amendment to Lease, effective as of January 4, 2021, by and between Revance Therapeutics, Inc. and 1222 Demonbreun, LP
Lease Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2021
Office Lease Agreement dated November 19, 2020
Lease Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
TN
2020
Fifth Amendment to Lease, dated July 1, 2020, by and between Revance Therapeutics, Inc. and BMR-Pacific Research Center LP
Lease Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2020
Fourth Amendment to Lease, dated May 10, 2018, by and between the Company and BMR-Pacific Research Center LP
Lease Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2018
THIRD AMENDMENT TO LEASE
Lease Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2014